Skip to content

Curcumin with reducing symptoms in premenstrual women in Thailand

Curcumin with reducing symptoms in premenstrual women in Thailand

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20210219006
Enrollment
36
Registered
2021-02-19
Start date
2021-02-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

moderate-severe premenstrual syndromes from PSST Questionnaire PMS Premenstrual syndromes Curcumin

Interventions

Oral curcumin 250 mg 1 tab twice a day (total 2 tabs 500 mg per day) Total 10 days : 7 days before first day of menstrual period and 3 days after first day of menstrual period,Lactose 250 mg 1 tab twi
Experimental Dietary Supplement,Placebo Comparator No treatment

Sponsors

None listed

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Thai female, 2. Regular menstrual cycle about 21-35 days, 3. No any underlying disease, 4. No any drug or supplement use, 5. No more than one drink a day, 6. No allergic history of curcumin, 7. Consent to participate in study, 8. Can participate study 12 weeks completely

Exclusion criteria

Exclusion criteria: 1. Need medication or supplement including contraceptive drug, Painkillers relieve symptoms during the period in the premenstrual syndrome, 2. Pregnancy, 3. Curcumin allergy, 4. Lack of supplementation more than 2 consecutive days, 5. Can not resist the side effect from curcumin, 6. Have a condition or disease that is dangerous to health occurred during the study, 7. Refuse to participate in a research study for a period of time after entering a research study

Design outcomes

Primary

MeasureTime frame
stage of symptom: mild and moderate-severe 3 months PSST Questionnaire,PMS score 3 months PSST Questionnaire

Secondary

MeasureTime frame
N/A N/A N/A

Countries

Thailand

Contacts

Public ContactWaralee Amarintarovat

Durakij Pundit University

waralee.ama@gmail.com0655169266

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026